0.023180
0.000000
0.000000
0.000000
0.011663
0.000000
0.000000
0.000000
0.015494
0.00000
0.00000
0.00000
Klabunde, T.
Petrassi, H.M.
Oza, V.B.
Kelly, J.W.
Sacchettini, J.C.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
8
90.00
90.00
90.00
43.140
85.740
64.540
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C14 H11 Cl2 N O2
296.149
2-[2,6-DICHLOROPHENYL)AMINO]BENZENEACETIC ACID
DICLOFENAC
non-polymer
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
H2 O
18.015
WATER
non-polymer
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Nat.Struct.Biol.
NSBIEW
2024
1072-8368
7
312
321
10.1038/74082
10742177
Rational design of potent human transthyretin amyloid disease inhibitors.
2000
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
293
1
IMAGE PLATE
1998-10-10
MACSCIENCE
SINGLE WAVELENGTH
M
x-ray
1
1.5418
1.0
1.5418
ROTATING ANODE
RIGAKU RU200
13420.968
TRANSTHYRETIN
2
man
polymer
296.149
2-[2,6-DICHLOROPHENYL)AMINO]BENZENEACETIC ACID
1
syn
non-polymer
18.015
water
52
nat
water
PREALBUMIN
no
no
GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEQFVEGIYKVEIDTKSYWK
ALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTN
GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEQFVEGIYKVEIDTKSYWK
ALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTN
A,B
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
Escherichia
sample
9606
Homo sapiens
562
Escherichia coli
1
2.22
44.65
VAPOR DIFFUSION, HANGING DROP
7.4
potassium chloride
potassium phosphate
ammonium sulfate, pH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 293K
293
repository
Initial release
Version format compliance
Derived calculations
Version format compliance
1
0
2001-01-23
1
1
2008-04-27
1
2
2011-07-13
HUMAN TRANSTHYRETIN (PREALBUMIN)
CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN
CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN IN COMPLEX WITH RESVERATROL
CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN IN COMPLEX WITH FLURBIPROFEN
CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN IN COMPLEX WITH DIBENZOFURAN-4,6-DICARBOXYLIC ACID
CRYSTAL STRUCTURE OF TRANSTHYRETIN IN COMPLEX WITH N-(M-TRIFLUOROMETHYLPHENYL)
PHENOXAZINE-4,6-DICARBOXYLIC ACID
CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN IN COMPLEX WITH O-TRIFLUOROMETHYLPHENYL
ANTHRANILIC ACID
RCSB
Y
RCSB
2000-01-23
REL
DIF
2-[2,6-DICHLOROPHENYL)AMINO]BENZENEACETIC ACID
HOH
water
DIC
1
2
DIF
DIF
125
B
WAT
100
3
HOH
HOH
125
A
WAT
101
3
HOH
HOH
126
A
WAT
104
3
HOH
HOH
127
A
WAT
106
3
HOH
HOH
128
A
WAT
107
3
HOH
HOH
129
A
WAT
110
3
HOH
HOH
130
A
WAT
111
3
HOH
HOH
131
A
WAT
113
3
HOH
HOH
132
A
WAT
114
3
HOH
HOH
133
A
WAT
115
3
HOH
HOH
134
A
WAT
118
3
HOH
HOH
135
A
WAT
119
3
HOH
HOH
136
A
WAT
120
3
HOH
HOH
137
A
WAT
123
3
HOH
HOH
138
A
WAT
124
3
HOH
HOH
139
A
WAT
126
3
HOH
HOH
140
A
WAT
128
3
HOH
HOH
141
A
WAT
129
3
HOH
HOH
142
A
WAT
134
3
HOH
HOH
143
A
WAT
135
3
HOH
HOH
144
A
WAT
136
3
HOH
HOH
145
A
WAT
137
3
HOH
HOH
146
A
WAT
138
3
HOH
HOH
147
A
WAT
139
3
HOH
HOH
148
A
WAT
141
3
HOH
HOH
149
A
WAT
142
3
HOH
HOH
150
A
WAT
145
3
HOH
HOH
151
A
WAT
146
3
HOH
HOH
152
A
WAT
148
3
HOH
HOH
153
A
WAT
149
3
HOH
HOH
154
A
WAT
151
3
HOH
HOH
155
A
WAT
102
3
HOH
HOH
126
B
WAT
103
3
HOH
HOH
127
B
WAT
105
3
HOH
HOH
128
B
WAT
108
3
HOH
HOH
129
B
WAT
109
3
HOH
HOH
130
B
WAT
112
3
HOH
HOH
131
B
WAT
116
3
HOH
HOH
132
B
WAT
117
3
HOH
HOH
133
B
WAT
121
3
HOH
HOH
134
B
WAT
122
3
HOH
HOH
135
B
WAT
125
3
HOH
HOH
136
B
WAT
127
3
HOH
HOH
137
B
WAT
130
3
HOH
HOH
138
B
WAT
131
3
HOH
HOH
139
B
WAT
132
3
HOH
HOH
140
B
WAT
133
3
HOH
HOH
141
B
WAT
140
3
HOH
HOH
142
B
WAT
143
3
HOH
HOH
143
B
WAT
144
3
HOH
HOH
144
B
WAT
147
3
HOH
HOH
145
B
WAT
150
3
HOH
HOH
146
B
n
1
1
A
n
2
2
A
n
3
3
A
n
4
4
A
n
5
5
A
n
6
6
A
n
7
7
A
n
8
8
A
n
9
9
A
CYS
10
n
10
CYS
10
A
PRO
11
n
11
PRO
11
A
LEU
12
n
12
LEU
12
A
MET
13
n
13
MET
13
A
VAL
14
n
14
VAL
14
A
LYS
15
n
15
LYS
15
A
VAL
16
n
16
VAL
16
A
LEU
17
n
17
LEU
17
A
ASP
18
n
18
ASP
18
A
ALA
19
n
19
ALA
19
A
VAL
20
n
20
VAL
20
A
ARG
21
n
21
ARG
21
A
GLY
22
n
22
GLY
22
A
SER
23
n
23
SER
23
A
PRO
24
n
24
PRO
24
A
ALA
25
n
25
ALA
25
A
ILE
26
n
26
ILE
26
A
ASN
27
n
27
ASN
27
A
VAL
28
n
28
VAL
28
A
ALA
29
n
29
ALA
29
A
VAL
30
n
30
VAL
30
A
HIS
31
n
31
HIS
31
A
VAL
32
n
32
VAL
32
A
PHE
33
n
33
PHE
33
A
ARG
34
n
34
ARG
34
A
LYS
35
n
35
LYS
35
A
ALA
36
n
36
ALA
36
A
ALA
37
n
37
ALA
37
A
ASP
38
n
38
ASP
38
A
ASP
39
n
39
ASP
39
A
THR
40
n
40
THR
40
A
TRP
41
n
41
TRP
41
A
GLU
42
n
42
GLU
42
A
PRO
43
n
43
PRO
43
A
PHE
44
n
44
PHE
44
A
ALA
45
n
45
ALA
45
A
SER
46
n
46
SER
46
A
GLY
47
n
47
GLY
47
A
LYS
48
n
48
LYS
48
A
THR
49
n
49
THR
49
A
SER
50
n
50
SER
50
A
GLU
51
n
51
GLU
51
A
SER
52
n
52
SER
52
A
GLY
53
n
53
GLY
53
A
GLU
54
n
54
GLU
54
A
LEU
55
n
55
LEU
55
A
HIS
56
n
56
HIS
56
A
GLY
57
n
57
GLY
57
A
LEU
58
n
58
LEU
58
A
THR
59
n
59
THR
59
A
THR
60
n
60
THR
60
A
GLU
61
n
61
GLU
61
A
GLU
62
n
62
GLU
62
A
GLN
63
n
63
GLN
63
A
PHE
64
n
64
PHE
64
A
VAL
65
n
65
VAL
65
A
GLU
66
n
66
GLU
66
A
GLY
67
n
67
GLY
67
A
ILE
68
n
68
ILE
68
A
TYR
69
n
69
TYR
69
A
LYS
70
n
70
LYS
70
A
VAL
71
n
71
VAL
71
A
GLU
72
n
72
GLU
72
A
ILE
73
n
73
ILE
73
A
ASP
74
n
74
ASP
74
A
THR
75
n
75
THR
75
A
LYS
76
n
76
LYS
76
A
SER
77
n
77
SER
77
A
TYR
78
n
78
TYR
78
A
TRP
79
n
79
TRP
79
A
LYS
80
n
80
LYS
80
A
ALA
81
n
81
ALA
81
A
LEU
82
n
82
LEU
82
A
GLY
83
n
83
GLY
83
A
ILE
84
n
84
ILE
84
A
SER
85
n
85
SER
85
A
PRO
86
n
86
PRO
86
A
PHE
87
n
87
PHE
87
A
HIS
88
n
88
HIS
88
A
GLU
89
n
89
GLU
89
A
HIS
90
n
90
HIS
90
A
ALA
91
n
91
ALA
91
A
GLU
92
n
92
GLU
92
A
VAL
93
n
93
VAL
93
A
VAL
94
n
94
VAL
94
A
PHE
95
n
95
PHE
95
A
THR
96
n
96
THR
96
A
ALA
97
n
97
ALA
97
A
ASN
98
n
98
ASN
98
A
ASP
99
n
99
ASP
99
A
SER
100
n
100
SER
100
A
GLY
101
n
101
GLY
101
A
PRO
102
n
102
PRO
102
A
ARG
103
n
103
ARG
103
A
ARG
104
n
104
ARG
104
A
TYR
105
n
105
TYR
105
A
THR
106
n
106
THR
106
A
ILE
107
n
107
ILE
107
A
ALA
108
n
108
ALA
108
A
ALA
109
n
109
ALA
109
A
LEU
110
n
110
LEU
110
A
LEU
111
n
111
LEU
111
A
SER
112
n
112
SER
112
A
PRO
113
n
113
PRO
113
A
TYR
114
n
114
TYR
114
A
SER
115
n
115
SER
115
A
TYR
116
n
116
TYR
116
A
SER
117
n
117
SER
117
A
THR
118
n
118
THR
118
A
THR
119
n
119
THR
119
A
ALA
120
n
120
ALA
120
A
VAL
121
n
121
VAL
121
A
VAL
122
n
122
VAL
122
A
THR
123
n
123
THR
123
A
ASN
124
n
124
ASN
124
A
n
1
1
B
n
2
2
B
n
3
3
B
n
4
4
B
n
5
5
B
n
6
6
B
n
7
7
B
n
8
8
B
n
9
9
B
CYS
10
n
10
CYS
10
B
PRO
11
n
11
PRO
11
B
LEU
12
n
12
LEU
12
B
MET
13
n
13
MET
13
B
VAL
14
n
14
VAL
14
B
LYS
15
n
15
LYS
15
B
VAL
16
n
16
VAL
16
B
LEU
17
n
17
LEU
17
B
ASP
18
n
18
ASP
18
B
ALA
19
n
19
ALA
19
B
VAL
20
n
20
VAL
20
B
ARG
21
n
21
ARG
21
B
GLY
22
n
22
GLY
22
B
SER
23
n
23
SER
23
B
PRO
24
n
24
PRO
24
B
ALA
25
n
25
ALA
25
B
ILE
26
n
26
ILE
26
B
ASN
27
n
27
ASN
27
B
VAL
28
n
28
VAL
28
B
ALA
29
n
29
ALA
29
B
VAL
30
n
30
VAL
30
B
HIS
31
n
31
HIS
31
B
VAL
32
n
32
VAL
32
B
PHE
33
n
33
PHE
33
B
ARG
34
n
34
ARG
34
B
LYS
35
n
35
LYS
35
B
ALA
36
n
36
ALA
36
B
ALA
37
n
37
ALA
37
B
ASP
38
n
38
ASP
38
B
ASP
39
n
39
ASP
39
B
THR
40
n
40
THR
40
B
TRP
41
n
41
TRP
41
B
GLU
42
n
42
GLU
42
B
PRO
43
n
43
PRO
43
B
PHE
44
n
44
PHE
44
B
ALA
45
n
45
ALA
45
B
SER
46
n
46
SER
46
B
GLY
47
n
47
GLY
47
B
LYS
48
n
48
LYS
48
B
THR
49
n
49
THR
49
B
SER
50
n
50
SER
50
B
GLU
51
n
51
GLU
51
B
SER
52
n
52
SER
52
B
GLY
53
n
53
GLY
53
B
GLU
54
n
54
GLU
54
B
LEU
55
n
55
LEU
55
B
HIS
56
n
56
HIS
56
B
GLY
57
n
57
GLY
57
B
LEU
58
n
58
LEU
58
B
THR
59
n
59
THR
59
B
THR
60
n
60
THR
60
B
GLU
61
n
61
GLU
61
B
GLU
62
n
62
GLU
62
B
GLN
63
n
63
GLN
63
B
PHE
64
n
64
PHE
64
B
VAL
65
n
65
VAL
65
B
GLU
66
n
66
GLU
66
B
GLY
67
n
67
GLY
67
B
ILE
68
n
68
ILE
68
B
TYR
69
n
69
TYR
69
B
LYS
70
n
70
LYS
70
B
VAL
71
n
71
VAL
71
B
GLU
72
n
72
GLU
72
B
ILE
73
n
73
ILE
73
B
ASP
74
n
74
ASP
74
B
THR
75
n
75
THR
75
B
LYS
76
n
76
LYS
76
B
SER
77
n
77
SER
77
B
TYR
78
n
78
TYR
78
B
TRP
79
n
79
TRP
79
B
LYS
80
n
80
LYS
80
B
ALA
81
n
81
ALA
81
B
LEU
82
n
82
LEU
82
B
GLY
83
n
83
GLY
83
B
ILE
84
n
84
ILE
84
B
SER
85
n
85
SER
85
B
PRO
86
n
86
PRO
86
B
PHE
87
n
87
PHE
87
B
HIS
88
n
88
HIS
88
B
GLU
89
n
89
GLU
89
B
HIS
90
n
90
HIS
90
B
ALA
91
n
91
ALA
91
B
GLU
92
n
92
GLU
92
B
VAL
93
n
93
VAL
93
B
VAL
94
n
94
VAL
94
B
PHE
95
n
95
PHE
95
B
THR
96
n
96
THR
96
B
ALA
97
n
97
ALA
97
B
ASN
98
n
98
ASN
98
B
ASP
99
n
99
ASP
99
B
SER
100
n
100
SER
100
B
GLY
101
n
101
GLY
101
B
PRO
102
n
102
PRO
102
B
ARG
103
n
103
ARG
103
B
ARG
104
n
104
ARG
104
B
TYR
105
n
105
TYR
105
B
THR
106
n
106
THR
106
B
ILE
107
n
107
ILE
107
B
ALA
108
n
108
ALA
108
B
ALA
109
n
109
ALA
109
B
LEU
110
n
110
LEU
110
B
LEU
111
n
111
LEU
111
B
SER
112
n
112
SER
112
B
PRO
113
n
113
PRO
113
B
TYR
114
n
114
TYR
114
B
SER
115
n
115
SER
115
B
TYR
116
n
116
TYR
116
B
SER
117
n
117
SER
117
B
THR
118
n
118
THR
118
B
THR
119
n
119
THR
119
B
ALA
120
n
120
ALA
120
B
VAL
121
n
121
VAL
121
B
VAL
122
n
122
VAL
122
B
THR
123
n
123
THR
123
B
n
124
124
B
author_and_software_defined_assembly
PISA,PQS
4
tetrameric
7360
-60
18190
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
-1.0000000000
0.0000000000
0.0000000000
0.0000000000
-1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
2_665
-x+1,-y+1,z
crystal symmetry operation
43.1400000000
85.7400000000
0.0000000000
A
O
SER
23
A
O
SER
23
A
N
ASP
18
A
N
ASP
18
A
N
MET
13
A
N
MET
13
A
O
TYR
105
A
O
TYR
105
A
N
SER
112
A
N
SER
112
A
O
SER
115
A
O
SER
115
A
N
THR
118
A
N
THR
118
B
O
TYR
116
B
O
TYR
116
B
O
THR
123
B
O
THR
123
B
N
ARG
104
B
N
ARG
104
B
O
TYR
105
B
O
TYR
105
B
N
MET
13
B
N
MET
13
B
N
ASP
18
B
N
ASP
18
B
O
SER
23
B
O
SER
23
A
N
LEU
55
A
N
LEU
55
A
O
VAL
14
A
O
VAL
14
A
N
MET
13
A
N
MET
13
A
O
TYR
105
A
O
TYR
105
A
N
SER
112
A
N
SER
112
A
O
SER
115
A
O
SER
115
A
N
THR
118
A
N
THR
118
B
O
TYR
116
B
O
TYR
116
B
O
THR
123
B
O
THR
123
B
N
ARG
104
B
N
ARG
104
B
O
TYR
105
B
O
TYR
105
B
N
MET
13
B
N
MET
13
B
O
VAL
14
B
O
VAL
14
B
N
LEU
55
B
N
LEU
55
A
O
GLY
47
A
O
GLY
47
A
N
VAL
30
A
N
VAL
30
A
N
LYS
35
A
N
LYS
35
A
O
ILE
68
A
O
ILE
68
A
N
ILE
73
A
N
ILE
73
A
O
ALA
91
A
O
ALA
91
A
O
VAL
94
A
O
VAL
94
B
N
GLU
89
B
N
GLU
89
B
N
ALA
97
B
N
ALA
97
B
O
GLY
67
B
O
GLY
67
B
N
GLU
72
B
N
GLU
72
B
O
HIS
31
B
O
HIS
31
B
O
ARG
34
B
O
ARG
34
B
N
GLU
42
B
N
GLU
42
1
B
DIF
125
C
DIF
1
A
GLY
1
A
GLY
1
1
Y
1
A
PRO
2
A
PRO
2
1
Y
1
A
THR
3
A
THR
3
1
Y
1
A
GLY
4
A
GLY
4
1
Y
1
A
THR
5
A
THR
5
1
Y
1
A
GLY
6
A
GLY
6
1
Y
1
A
GLU
7
A
GLU
7
1
Y
1
A
SER
8
A
SER
8
1
Y
1
A
LYS
9
A
LYS
9
1
Y
1
B
GLY
1
B
GLY
1
1
Y
1
B
PRO
2
B
PRO
2
1
Y
1
B
THR
3
B
THR
3
1
Y
1
B
GLY
4
B
GLY
4
1
Y
1
B
THR
5
B
THR
5
1
Y
1
B
GLY
6
B
GLY
6
1
Y
1
B
GLU
7
B
GLU
7
1
Y
1
B
SER
8
B
SER
8
1
Y
1
B
LYS
9
B
LYS
9
1
Y
1
B
ASN
124
B
ASN
124
1
Y
1
B
ASP
99
65.15
63.70
1
B
PRO
102
-54.73
105.42
The structure contains two diclofenac molecules that bind in each of two independent binding sites of the tetramer. Since the binding is along the 2-fold crystallographic axis, an occupancy of 0.5 corresponds to saturation of each of the binding sites.
Binding of diclofenac in two symmetry-related binding modes induces alternate side chain conformations for the protein residues Val17, Ser117, and Thr119.
0.2150000
0.1920000
2
8
1590
16078
15655
95.0
randomly chosen subset of 10 % of the observed reflections
1
2
Engh & Huber
2
8
52
1842
19
0
1771
1.260
0.006
2
20
1DVX
16154
16154
0
0
0.0860000
1
9.9
4.48
97.1
0.2170000
1.9
2.0
1
90.5
refinement
CNS
data reduction
DENZO
data scaling
SCALEPACK
phasing
CNS
TRANSTHYRETIN / DICLOFENAC COMPLEX
CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN IN COMPLEX WITH DICLOFENAC
1
N
N
1
N
N
2
N
N
3
N
N
3
N
N
The biological assembly is a tetramer constructed from the homodimer (chain A and B) and a symmetry mate generated by the two-fold
A
ASP
74
A
ASP
74
HELX_P
A
LEU
82
A
LEU
82
1
1
9
B
ASP
74
B
ASP
74
HELX_P
B
LEU
82
B
LEU
82
1
2
9
covale
2.028
A
A
B
DIF
125
C
CL4
DIF
1_555
A
LEU
17
A
CD1
LEU
17
2_665
HORMONE/GROWTH FACTOR
THYROXINE TRANSPORT, SIGNALING PROTEIN, HORMONE-GROWTH FACTOR COMPLEX
TTHY_HUMAN
UNP
1
1
P02766
GPTGTGESKCPLMVKVLDAVRGSPAINVAMHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWK
ALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTN
1
124
1DVX
1
124
P02766
A
1
1
124
1
124
1DVX
1
124
P02766
B
1
1
124
8
8
8
anti-parallel
parallel
anti-parallel
anti-parallel
anti-parallel
parallel
anti-parallel
anti-parallel
parallel
anti-parallel
anti-parallel
anti-parallel
parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
A
SER
23
A
SER
23
A
PRO
24
A
PRO
24
A
LEU
12
A
LEU
12
A
ASP
18
A
ASP
18
A
ARG
104
A
ARG
104
A
SER
112
A
SER
112
A
SER
115
A
SER
115
A
THR
123
A
THR
123
B
SER
115
B
SER
115
B
THR
123
B
THR
123
B
ARG
104
B
ARG
104
B
SER
112
B
SER
112
B
LEU
12
B
LEU
12
B
ASP
18
B
ASP
18
B
SER
23
B
SER
23
B
PRO
24
B
PRO
24
A
GLU
54
A
GLU
54
A
LEU
55
A
LEU
55
A
LEU
12
A
LEU
12
A
ASP
18
A
ASP
18
A
ARG
104
A
ARG
104
A
SER
112
A
SER
112
A
SER
115
A
SER
115
A
THR
123
A
THR
123
B
SER
115
B
SER
115
B
THR
123
B
THR
123
B
ARG
104
B
ARG
104
B
SER
112
B
SER
112
B
LEU
12
B
LEU
12
B
ASP
18
B
ASP
18
B
GLU
54
B
GLU
54
B
LEU
55
B
LEU
55
A
TRP
41
A
TRP
41
A
LYS
48
A
LYS
48
A
ALA
29
A
ALA
29
A
LYS
35
A
LYS
35
A
GLY
67
A
GLY
67
A
ILE
73
A
ILE
73
A
HIS
88
A
HIS
88
A
ALA
97
A
ALA
97
B
HIS
88
B
HIS
88
B
ALA
97
B
ALA
97
B
GLY
67
B
GLY
67
B
ILE
73
B
ILE
73
B
ALA
29
B
ALA
29
B
LYS
35
B
LYS
35
B
TRP
41
B
TRP
41
B
LYS
48
B
LYS
48
BINDING SITE FOR RESIDUE DIF B 125
Software
25
A
LYS
15
A
LYS
15
25
2_665
A
LEU
17
A
LEU
17
25
2_665
A
LEU
17
A
LEU
17
25
1_555
A
ALA
108
A
ALA
108
25
1_555
A
ALA
108
A
ALA
108
25
2_665
A
ALA
109
A
ALA
109
25
2_665
A
LEU
110
A
LEU
110
25
2_665
A
LEU
110
A
LEU
110
25
1_555
A
SER
117
A
SER
117
25
2_665
A
SER
117
A
SER
117
25
1_555
A
THR
118
A
THR
118
25
1_555
A
THR
119
A
THR
119
25
1_555
B
LYS
15
B
LYS
15
25
2_665
B
LEU
17
B
LEU
17
25
2_665
B
LEU
17
B
LEU
17
25
1_555
B
ALA
108
B
ALA
108
25
1_555
B
ALA
108
B
ALA
108
25
2_665
B
LEU
110
B
LEU
110
25
2_665
B
LEU
110
B
LEU
110
25
1_555
B
SER
117
B
SER
117
25
2_665
B
SER
117
B
SER
117
25
1_555
B
THR
118
B
THR
118
25
1_555
B
THR
119
B
THR
119
25
2_665
B
THR
119
B
THR
119
25
1_555
B
VAL
121
B
VAL
121
25
1_555
18
P 21 21 2